Target intelligence / Profile preview

Antibody-dependent cell cytotoxicity (ADCC)

Target
ADCC
Molecular classification
Immune mechanism
01

Overview

Antibody-dependent cell cytotoxicity (ADCC) is an immune mechanism where effector cells (e.g., NK cells, macrophages) kill antibody-coated target cells (e.g., virus-infected or cancerous cells). Antibodies bind to the target cell surface, and the Fc region of the antibody is recognized by Fc receptors on effector cells, leading to target cell lysis or apoptosis.

Other names
Antibody-dependent cellular cytotoxicityAntibody-dependent cell-mediated cytotoxicity
02

Mechanism of action

Antibodies bind to target cells via Fab, then effector cells (NK cells, macrophages, etc.) bind to the antibody's Fc region via Fc receptors, triggering the release of cytotoxic molecules (perforin, granzymes) or death-inducing ligands, leading to target cell lysis or apoptosis.

03

Biological functions

Immune responseCell killingViral clearanceTumor surveillanceParasite defense
04

Disease associations

Viral infectionsCancerParasitic infections
05

Safety considerations

Cytokine release syndromeOff-target effects of antibodiesImmune-related adverse events
06

Interacting drugs

Therapeutic monoclonal antibodies (e.g., rituximab, trastuzumab)

1 more in the full profile.

07

Biomarkers

Fc receptor polymorphismsAntibody glycosylation patternsNK cell activity

Beyond the preview

Go deeper on Antibody-dependent cell cytotoxicity (ADCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antibody-dependent cell cytotoxicity (ADCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call